Announcement

Announcement Module
Collapse
No announcement yet.

NCCN Practice Guidelines

Page Title Module
Move Remove Collapse
X
Conversation Detail Module
Collapse
  • Filter
  • Time
  • Show
Clear All
new posts

  • NCCN Practice Guidelines

    One of the best documents on testicular cancer treatment options is the National Comprehensive Cancer Network's Clinical Practice Guidelines in Oncology for Testicular Cancer.
    Scott, scott@tc-cancer.com
    right inguinal orchiectomy 6/5/2003 > nonseminoma, stage I > surveillance > L-RPLND 6/24/2005 for recurrence, suspected teratoma but found seminoma, stage II > chylous ascites until 9/2005 > surveillance and "all clear" since


    Your donation funds LIVESTRONG Foundation services for people facing cancer now. Please join me!

  • #2
    Updated NCCN Guidelines Available

    The 2008 version of the NCCN Clinical Practice Guidelines for the treatment of Testicular Cancer are now available online. Three updates have been made:
    • The treatment of stage IA, IB, and IS seminoma with single agent carboplatin has been changed from a category 3 to a category 2B designation. This means that adjuvant carboplatin is now considered to be (non-uniformly but without major disagreements) an acceptable treatment for stage I seminoma.
    • RPLNDs are specified as "open nerve sparing".
    • A palliative treatment recommendation of gemcitabine and oxaliplatin (GEMOX) has been added as second line salvage therapy.
    .
    For the guidelines for all types of cancer, see http://www.nccn.org.
    "Life moves pretty fast; if you don't stop and look around once in a while, you could miss it." -Ferris Bueller
    11.22.06 -Dx the day before Thanksgiving
    12.09.06 -Rt I/O; 100% seminoma, multifocal; Stage I-A; Surveillance; Six years out! I consider myself cured.

    Comment

    Working...
    X